文献速递血栓与止血

ADAMTS13缺乏与补体激活在血栓性微血管病发病中的协同作用

Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy.
PubMed 文献 · Blood · 2019-08-13

本研究在小鼠中探讨严重ADAMTS13缺乏与补体因子H突变是否协同导致血栓性微血管病(TMA)。单独Adamts13-/-或cfhW/R杂合突变小鼠无症状,而双突变小鼠出现血小板减少、低结合珠蛋白、外周血红细胞碎片增多、乳酸脱氢酶、血尿素氮和肌酐升高及死亡率增加,符合TMA表现;cfhR/R纯合突变无论是否合并Adamts13-/-均发生严重TMA,且双突变死亡率显著高于cfhR/R单突变。结果支持严重ADAMTS13缺乏与补体激活在TMA发病中具有协同效应。

要点

  • 单独ADAMTS13严重缺乏或cfhW/R杂合突变小鼠无症状,仅偶见微血管血栓。
  • Adamts13-/-cfhW/R双突变小鼠出现TMA表型及死亡率增加。
  • cfhR/R纯合突变导致严重TMA,合并ADAMTS13缺乏时死亡率更高。

核心结论

  • 小鼠实验结果支持严重ADAMTS13缺乏与补体激活在血栓性微血管病发病中具有协同效应。

研究设计与样本

  • 研究使用Adamts13-/-小鼠、cfhW/R杂合突变小鼠、cfhR/R纯合突变小鼠及Adamts13-/-cfhR/R双突变小鼠进行实验。

主要发现

  • Adamts13-/-或cfhW/R单独突变小鼠无症状,但各种组织偶见微血管血栓。
  • Adamts13-/-cfhW/R小鼠出现血小板减少、低结合珠蛋白、外周血涂片红细胞碎片增加、血浆乳酸脱氢酶活性、血尿素氮和肌酐升高及死亡率增加,符合TMA。
  • cfhR/R纯合突变无论是否合并Adamts13-/-均发生严重TMA,且Adamts13-/-cfhR/R小鼠死亡率显著高于cfhR/R单突变小鼠。
  • 组织学和免疫组化分析显示,安乐死或死亡小鼠的主要器官终末小动脉和毛细血管中存在播散性富含血小板的血栓。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe deficiency of plasma ADAMTS13 activity is the primary cause of thrombotic thrombocytopenic purpura (TTP) whereas overwhelming activation of complement via an alternative pathway results in atypical hemolytic uremic syndrome (aHUS), the prototypes of thrombotic microangiopathy (TMA). However, clinical and pathogenic distinctions between TTP and aHUS are often quite challenging. Clinical reports have suggested that complement activation may play a role in the development of TTP, which is caused by severe deficiency of plasma ADAMTS13 activity. However, the experimental evidence to support this hypothesis is still lacking. Here, we show that mice with either Adamts13 -/- or a heterozygous mutation of complement factor H (cfh) at amino acid residue of 1206 (ie, cfh W/R ) alone remain asymptomatic despite the presence of occasional microvascular thrombi in various organ tissues. However, mice carrying both Adamts13 -/- and cfh W/R exhibit thrombocytopenia, low haptoglobin, increased fragmentation of erythrocytes in peripheral blood smear, increased plasma levels of lactate dehydrogenase activity, blood urea nitrogen, and creatinine, as well as an increased mortality rate, consistent with the development of TMA. Moreover, mice with a homozygous mutation of cfh (ie, cfh R/R ) with or without Adamts13 -/- developed severe TMA. The mortality rate in mice with Adamts13 -/- cfh R/R was significantly higher than that in mice with cfh R/R alone. Histological and immunohistochemical analyses demonstrated the presence of disseminated platelet-rich thrombi in terminal arterioles and capillaries of major organ tissues in these mice that were either euthanized or died. Together, our results support a synergistic effect of severe ADAMTS13 deficiency and complement activation in pathogenesis of TMA in mice.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Zheng L, Zhang D, Cao W, et al. Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy. Blood. 2019. PMID: 31409673. doi:10.1182/blood.2019001040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。